Adverum Biotechnologies, Inc.
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the …
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
Adverum Biotechnologies, Inc. has no obligation with a government/award agency.
Latest Obligations
Spending By Type
Adverum Biotechnologies, Inc. can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of Adverum Biotechnologies, Inc..